Projected Income Statement: Celanese Corporation

Forecast Balance Sheet: Celanese Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 3,431 13,171 11,879 11,617 11,335 10,380 9,264 8,252
Change - 283.88% -9.81% -2.21% -2.43% -8.43% -10.75% -10.92%
Announcement Date 27/01/22 23/02/23 20/02/24 18/02/25 17/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Celanese Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 467 543 568 435 343 321 358 374.3
Change - 16.27% 4.6% -23.42% -21.15% -6.41% 11.53% 4.56%
Free Cash Flow (FCF) 1 1,290 1,276 1,320 498 773 784.3 896.6 960.4
Change - -1.09% 3.45% -62.27% 55.22% 1.46% 14.31% 7.12%
Announcement Date 27/01/22 23/02/23 20/02/24 18/02/25 17/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Celanese Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 33.21% 27.05% 22.34% 23.11% 19.83% 21.3% 21.25% 21.66%
EBIT Margin (%) 28.97% 22.44% 16.02% 16.03% 12.05% 13.6% 13.07% 13.59%
EBT Margin (%) 26.33% 14.69% 10.81% -9.69% -12.78% 6.1% 6.65% 8.42%
Net margin (%) 22.14% 19.58% 17.92% -14.81% -12.21% 5.69% 6.23% 7.28%
FCF margin (%) 15.11% 13.19% 12.07% 4.84% 8.1% 7.77% 8.81% 9.12%
FCF / Net Income (%) 68.25% 67.37% 67.35% -32.72% -66.35% 136.61% 141.41% 125.23%

Profitability

        
ROA 16.52% 9.07% 3.69% 3.7% 1.96% 2.84% 3.28% 4.07%
ROE 52.65% 35.29% 15.34% 14.92% 9.52% 14.36% 14.51% 15.01%

Financial Health

        
Leverage (Debt/EBITDA) 1.21x 5.03x 4.86x 4.89x 5.99x 4.83x 4.29x 3.62x
Debt / Free cash flow 2.66x 10.32x 9x 23.33x 14.66x 13.24x 10.33x 8.59x

Capital Intensity

        
CAPEX / Current Assets (%) 5.47% 5.61% 5.19% 4.23% 3.59% 3.18% 3.52% 3.55%
CAPEX / EBITDA (%) 16.47% 20.75% 23.24% 18.31% 18.12% 14.93% 16.56% 16.41%
CAPEX / FCF (%) 36.2% 42.55% 43.03% 87.35% 44.37% 40.93% 39.93% 38.98%

Items per share

        
Cash flow per share 1 15.67 16.66 17.36 8.838 10.45 10.22 12.23 13.05
Change - 6.28% 4.21% -49.08% 18.2% -2.16% 19.62% 6.72%
Dividend per Share 1 2.72 2.74 2.8 2.8 - 0.1293 0.1306 0.126
Change - 0.74% 2.19% 0% - - 1.03% -3.55%
Book Value Per Share 1 38.78 51.97 64.82 47.35 36.98 42.64 48.38 55.09
Change - 34.01% 24.73% -26.95% -21.9% 15.31% 13.46% 13.88%
EPS 1 16.86 17.34 17.92 -13.93 -10.64 5.336 5.748 6.923
Change - 2.85% 3.34% -177.73% 23.62% 150.15% 7.74% 20.44%
Nbr of stocks (in thousands) 108,871 108,428 108,855 109,312 109,505 109,663 109,663 109,663
Announcement Date 27/01/22 23/02/23 20/02/24 18/02/25 17/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E ratio 10.7x 9.95x
PBR 1.34x 1.18x
EV / Sales 1.65x 1.53x
Yield 0.23% 0.23%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
57.17USD
Average target price
74.25USD
Spread / Average Target
+29.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CE Stock
  4. Financials Celanese Corporation